Ettore Gilardoni

17PUBLICATIONS
69CO-AUTHORS
Molecular targetsRadiation therapyFree radical chemistryCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 16, 2026
A Small-Molecule Drug Conjugate Targeting FAP Exhibits Potent Activity in Dogs with Spontaneous Tumors.

|Apr 16, 2026
Quantitative Mass Spectrometry-Based Biodistribution of Monoclonal Antibodies: An Alternative to Radio-Biodistribution.

|Mar 28, 2026
The Carnosine-HNE Michael Adduct as a Redox-Active Species Associated with Nrf2-Dependent Antioxidant and Anti-Inflammatory Responses.

Alessandra Altomare, Giovanna Baron, Francesca Gado

|Feb 13, 2026
Combination with Immunocytokines Enhances the Anticancer Activity of Small Molecule Drug Conjugates and Radioligand Therapeutics Targeting Fibroblast Activation Protein.

Matilde Bocci, Laura Lucaroni, Domenico Ravazza

|Sep 30, 2025
Immunocompetent Mouse Models of Cancer Reveal the Superiority of Cellular Targets over Stromal Targets for the Development of Anticancer Bispecific Antibodies.

Stefanie K Pfister, Frauke Seehusen, Francesco Prisco

|Jun 30, 2025
Development of Multivalent FAP-Targeted Small Molecule-Drug Conjugates with Tailored MMAE Release Kinetics.

Matilde Bocci, Lucrezia Principi, Dario Neri

Pageof 3

Frequent Collaborators

8 joint publications

Samuele Cazzamalli

7 joint publications

Andrea Galbiati

6 joint publications

Matilde Bocci

5 joint publications

Lucrezia Principi